Requests that the FDA take a form of the indications and usage section of the Full Prescribing Label for Premarin tablets for dosages 0.30 mg and 0.45 mg be re-written
🏛 Food and Drug Administration (FDA)FDA-2025-P-6074
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.